- Home
- ELTK vs KRON Comparison
ELTK vs KRON Comparison
Compare ELTK & KRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTK
- KRON
- Stock Information
- Founded
- ELTK 1970
- KRON 2017
- Country
- ELTK Israel
- KRON United States
- Employees
- ELTK N/A
- KRON N/A
- Industry
- ELTK Electrical Products
- KRON Medicinal Chemicals and Botanical Products
- Sector
- ELTK Technology
- KRON Health Care
- Exchange
- ELTK Nasdaq
- KRON Nasdaq
- Market Cap
- ELTK 73.9M
- KRON 60.3M
- IPO Year
- ELTK 1997
- KRON 2020
- Fundamental
- Price
- ELTK $11.17
- KRON $0.90
- Analyst Decision
- ELTK
- KRON Buy
- Analyst Count
- ELTK 0
- KRON 3
- Target Price
- ELTK N/A
- KRON $1.63
- AVG Volume (30 Days)
- ELTK 21.9K
- KRON 184.6K
- Earning Date
- ELTK 11-19-2024
- KRON 11-13-2024
- Dividend Yield
- ELTK 1.99%
- KRON N/A
- EPS Growth
- ELTK N/A
- KRON N/A
- EPS
- ELTK 0.85
- KRON N/A
- Revenue
- ELTK $48,090,000.00
- KRON $9,864,000.00
- Revenue This Year
- ELTK $5.41
- KRON $52.58
- Revenue Next Year
- ELTK $12.11
- KRON N/A
- P/E Ratio
- ELTK $13.00
- KRON N/A
- Revenue Growth
- ELTK 7.22
- KRON 146.56
- 52 Week Low
- ELTK $9.00
- KRON $0.69
- 52 Week High
- ELTK $22.80
- KRON $1.60
- Technical
- Relative Strength Index (RSI)
- ELTK 54.37
- KRON 49.20
- Support Level
- ELTK $10.82
- KRON $0.84
- Resistance Level
- ELTK $12.00
- KRON $0.88
- Average True Range (ATR)
- ELTK 0.41
- KRON 0.05
- MACD
- ELTK 0.03
- KRON 0.00
- Stochastic Oscillator
- ELTK 42.36
- KRON 57.22
About ELTK Eltek Ltd.
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnects. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.